Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Cydan II Inc.

BioCentury | Jun 8, 2021
Management Tracks

McCourt named CEO at Ironwood; plus Guardant, Fusion, PepGen and more

Thomas McCourt, president and interim CEO at Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), will become permanent CEO and a board member. Gina Consylman, SVP and CFO at the gastrointestinal disease
BioCentury | Mar 27, 2019
Company News

Management tracks: Epic, Axcella, KalVista

BioCentury | Jan 5, 2019
Finance

Longitude takes a spin with Cydan

Why Longitude funded Cydan's latest spinout to makeover an Ipsen asset
BioCentury | Oct 20, 2017
Finance

Fast inflections

Why Longitude Capital joined Cydan's investor syndicate
BioCentury | Oct 20, 2017
Financial News

Orphan drug accelerator Cydan raises $34M

BioCentury | Oct 17, 2017
Financial News

Orphan drug accelerator Cydan raises $34M

Items per page:
1 - 8 of 8